THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS

被引：1
|
作者：
Erder, M. [1 ]
Chen, K. [2 ]
Wu, E. Q. [2 ]
Hodgkins, P. [1 ]
Sikirica, V [1 ]
机构：
[1] Shire Pharmaceut, Wayne, NJ USA
[2] Anal Grp Inc, Boston, MA USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.1061
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A192 / A192
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF GUANFACINE EXTENDED-RELEASE VERSUS ATOMOXETINE FOR THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CANADA
    Lachaine, J.
    Sikirica, V
    Mathurin, K.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A213 - A214
  • [2] Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
    Erder, M.
    Xie, Jipan
    Signorovitch, James
    Chen, Kristina
    Hodgkins, Paul
    Lu, Mei
    Wu, Eric
    Sikirica, Vanja
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2012, 10 (06) : 381 - 395
  • [3] Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)
    Turnbow, John
    Kollins, Scott
    Lopez, Frank
    Lyne, Andrew
    Youcha, Sharon
    Rubin, Jonathan
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 218S - 218S
  • [4] Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Connor, Daniel F.
    Arnsten, Amy F. T.
    Pearson, Geraldine S.
    Greco, Gabriella F.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1601 - 1610
  • [5] Cost-effectiveness of atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents
    Iskedjian, M
    Maturi, B
    Walker, JH
    Einarson, TR
    Khattak, S
    Carter, G
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 275 - 275
  • [6] A COST-EFFECTIVENESS ANALYSIS OF GUANFACINE EXTENDED-RELEASE TREATMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Maeda, S.
    Shimozuma, K.
    Takeda, Y.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A841 - A841
  • [7] Guanfacine Extended Release: A Novel Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Faraone, Stephen V.
    McBurnett, Keith
    Sallee, Floyd R.
    Steeber, Jennifer
    Lopez, Frank A.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (11) : 1778 - 1793
  • [8] Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD)
    Sallee, Floyd R.
    Eaton, Katherine
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (15) : 2549 - 2556
  • [9] Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder (vol 6, pg 381, 2012)
    Erder, M. Haim
    Xie, Jipan
    Signorovitch, James E.
    Chen, Kristina S.
    Hodgkins, Paul
    Lu, Mei
    Wu, Eric Q.
    Sikirica, Vanja
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2013, 11 (03) : 309 - 309
  • [10] Systematic literature review and mixed treatment comparison of guanfacine extended release (GXR) versus other pharmacotherapies in children and adolescents with attention deficit/hyperactivity disorder (ADHD)
    Joseph, A.
    Xie, J.
    Bischof, M.
    Zhanabekova, Z.
    Cai, S.
    Zhuo, Y.
    Huss, M.
    Sikirica, V.
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 : S166 - S167
12345